BioAge Labs Statistics

Total Valuation

BioAge Labs has a market cap or net worth of $774.30 million. The enterprise value is $494.28 million.

Market Cap	774.30M
Enterprise Value	494.28M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

BioAge Labs has 44.40 million shares outstanding. The number of shares has increased by 234.99% in one year.

Current Share Class	44.40M
Shares Outstanding	44.40M
Shares Change (YoY)	+234.99%
Shares Change (QoQ)	+0.92%
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	54.06%
Float	37.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	86.03
Forward PS	7.57
PB Ratio	2.40
P/TBV Ratio	2.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	54.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.24, with a Debt / Equity ratio of 0.02.

Current Ratio	14.24
Quick Ratio	14.06
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-133.11

Financial Efficiency

Return on equity (ROE) is -27.09% and return on invested capital (ROIC) is -19.03%.

Return on Equity (ROE)	-27.09%
Return on Assets (ROA)	-17.76%
Return on Invested Capital (ROIC)	-19.03%
Return on Capital Employed (ROCE)	-33.77%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$145,081
Profits Per Employee	-$1.30M
Employee Count	62
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +312.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+312.29%
50-Day Moving Average	18.93
200-Day Moving Average	11.70
Relative Strength Index (RSI)	47.24
Average Volume (20 Days)	415,273

Short Selling Information

The latest short interest is 1.75 million, so 3.93% of the outstanding shares have been sold short.

Short Interest	1.75M
Short Previous Month	1.56M
Short % of Shares Out	3.93%
Short % of Float	4.71%
Short Ratio (days to cover)	3.27

Income Statement

In the last 12 months, BioAge Labs had revenue of $9.00 million and -$80.61 million in losses. Loss per share was -$2.24.

Revenue	9.00M
Gross Profit	-64.97M
Operating Income	-92.78M
Pretax Income	-80.61M
Net Income	-80.61M
EBITDA	-92.57M
EBIT	-92.78M
Loss Per Share	-$2.24

Full Income Statement

Balance Sheet

The company has $281.10 million in cash and $5.56 million in debt, giving a net cash position of $279.57 million or $6.30 per share.

Cash & Cash Equivalents	281.10M
Total Debt	5.56M
Net Cash	279.57M
Net Cash Per Share	$6.30
Equity (Book Value)	272.05M
Book Value Per Share	7.28
Working Capital	266.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.63 million and capital expenditures -$719,000, giving a free cash flow of -$82.35 million.

Operating Cash Flow	-81.63M
Capital Expenditures	-719,000
Depreciation & Amortization	213,000
Net Borrowing	-6.00M
Free Cash Flow	-82.35M
FCF Per Share	-$1.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,031.46%
Pretax Margin	-896.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAge Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-234.99%
Shareholder Yield	-234.99%
Earnings Yield	-10.42%
FCF Yield	-10.64%

Analyst Forecast

The average price target for BioAge Labs is $51.50, which is 195.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$51.50
Price Target Difference	195.30%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	43.84%
EPS Growth Forecast (5Y)	-25.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAge Labs has an Altman Z-Score of 3.75 and a Piotroski F-Score of 1.

Altman Z-Score	3.75
Piotroski F-Score	1